Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Open in API
Filings indexed 643 across all filing types
Latest filing 2025-02-28 Earnings Release
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Observe Medical has received first UnoMeterT SafetiT Plus order from the largest UnoMeterT market and has received repeat orders from several countries.
Earnings Release Classification · 99% confidence The document is a short press release dated February 28th, 2025, announcing new orders received for the UnoMeterTM SafetiTM Plus product and providing commentary from the CEO regarding market performance and growth expectations. This type of announcement, focusing on recent business developments, order intake, and operational highlights, is characteristic of an Earnings Release (ER) or a general business update. Since it is not a full financial report (like 10-K or IR) but rather a summary of recent positive operational news, 'ER' (Earnings Release) is the most appropriate classification, as these often include key operational metrics alongside preliminary financial context, or serve as a precursor to a full earnings report. Given the brevity and focus on order intake, it fits the 'ER' definition better than a general 'RNS' or 'RPA'. FY 2025
2025-02-28 English
Observe Medical has received first UnoMeterT SafetiT Plus order from the largest UnoMeterT market and has received repeat orders from several countries.
Regulatory Filings Classification · 95% confidence The document is a short press release dated February 28, 2025, announcing new orders and positive feedback for the UnoMeterT SafetiT Plus product, including securing an order from the UK market. This type of announcement, focusing on operational updates, sales intake, and management commentary outside of mandated financial reporting periods (like 10-K or IR), typically falls under a general regulatory announcement or news release. Since it is not a formal financial report (10-K, IR, ER, MRQ) and does not fit specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory news releases.
2025-02-28 English
Observe Medical ASA - Resignation of board member
Board/Management Information Classification · 100% confidence The document explicitly announces the resignation of a board member, Kathrine Elisabeth Gamborg Andreassen, from the board of directors of Observe Medical ASA. This content directly relates to changes in the company's board of directors or senior management. According to the definitions, this aligns perfectly with the 'Board/Management Information' category (Code: MANG). The document is short and is an announcement, not a comprehensive report or transcript.
2025-02-04 English
Observe Medical ASA: Ex. reverse share split and new ISIN today
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces a 'Reverse share split' and a 'new ISIN' effective on a specific date (14 January 2025). This action directly relates to a change in the company's capital structure (the number of shares and nominal value). Reviewing the definitions, the 'Share Issue/Capital Change' (SHA) category is the most appropriate fit for corporate actions that alter the share count or structure, such as a reverse split. It is not an earnings release, an AGM material, or a simple announcement of a report.
2025-01-14 English
CORRECTION - Observe Medical ASA: Key information relating to share reverse split
Share Issue/Capital Change Classification · 98% confidence The document explicitly details a 'share reverse split' including the ratio, key dates (Last day including right, Ex-date, Record date), and mentions the issuance of a new ISIN. A reverse split is a change in the capital structure of the company. Based on the definitions, 'Share Issue/Capital Change (Code: SHA)' is the most appropriate category for actions that alter the number or structure of outstanding shares, such as a reverse split. The document is short and appears to be a direct regulatory announcement, not an announcement of a larger report.
2025-01-10 English
Observe Medical ASA: Key information relating to change of ISIN
Regulatory Filings Classification · 98% confidence The document is a short announcement from Observe Medical ASA regarding a change in its International Securities Identification Number (ISIN). It specifies the previous ISIN, the new ISIN, and the effective date (14 January 2025). It explicitly states this information is published in accordance with the Continuing Obligations for companies listed on the Oslo Stock Exchange and Euronext Expand. This type of mandatory, non-financial, administrative update that doesn't fit into specific categories like dividends, director dealings, or capital changes is best classified as a general regulatory announcement or filing. Since it is a mandatory disclosure to the exchange that doesn't fit the other specific codes (like CAP for financing or SHA for share structure changes), the most appropriate fallback is Regulatory Filings (RNS). The document length is very short (1576 chars), confirming it is an announcement, not a comprehensive report.
2025-01-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.